We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Blue drug capsule with lower half made from computer network and the upper half containing small human brains.
Industry Insight

AI-Powered Platforms Are Making Complex Data Usable for Drug Discovery

In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and shaping the future of AI-powered drug discovery.
A researcher holding up a drug vial to the camera. A image of a DNA double helix is digitally-superimposed onto the blue liquid in the vial.
Industry Insight

Circular RNA: The Next Frontier for RNA Therapeutics?

Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines.
Young scientists collaborating in a modern lab, researching for biotech start-up innovations.
Industry Insight

How Biotech Startups Are Redefining 3D Models and Sustainability in Drug Discovery

Explore how biotech start-ups are using 3D models and automation to reduce animal testing, cut waste and improve drug discovery outcomes.
A doctor in a white coat with an outstretched hand. In the hand is a digitally-imposed red and white drug pill, shimmering with data-like light points surrounding it.
Industry Insight

Can Patients Trust a Drug Designed By AI?

Patient trust is vital as AI transforms pharma and drug discovery. Discover how transparency and regulation are making innovation safer.
A businessman in a suit handing out fanned $100 bills, symbolizing crowdfunding investment.
Industry Insight

How Crowdfunding Could Change the Cell and Gene Therapy Investor Landscape

Discover how crowdfunding could help biotech startups and cell and gene therapy developers overcome funding barriers by engaging patients, physicians and everyday investors.
A scientist holding a vial with a graphic of DNA, representing AAV quantification in gene therapy.
Industry Insight

Improving the Accessibility of AAV Quantification in Gene Therapy Development

Learn how the Amperia platform improves AAV quantification accuracy and speed, making gene therapy development more accessible and consistent.
A scientist holding a test tube with a small amount of red liquid in it, in front of a large model of a DNA double-helix.
Industry Insight

Overcoming Toxicity Challenges in Gene Therapy

Explore the dosing challenges posed by current gene therapies and how circular RNA may unlock more potent and safer therapies.
A small baby's hand holding the thumb of a parent.
Industry Insight

The Challenges of Conducting Rare Disease Clinical Trials

Explore the unique issues of rare disease trials and how “gene silencing” therapies could reshape the future for patients with H-ABC.
The outline of a trophy against a blue background, representing the ELRIG Drug Discovery Innovation Award.
Industry Insight

Lipid-Free Cell Delivery System Wins ELRIG Drug Discovery 2025 Innovation Award

ELRIG Drug Discovery 2025 recognizes BubbleFect, a lipid-free cell delivery system that utilizes phase separation peptides for non-viral gene therapy delivery.
A female doctor talking to a cancer patient receiving treatment in hospital.
Industry Insight

$3.4 Billion Acquisition To Bring Life-Changing Therapies to More Rare Tumor Patients

Discover how one of the biggest biopharma acquisitions of 2025 aims to expand rare tumor therapies for hard-to-treat cancers like desmoid tumors.
Advertisement